Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

42.89USD
14 Dec 2017
Change (% chg)

$-1.25 (-2.83%)
Prev Close
$44.14
Open
$44.45
Day's High
$44.45
Day's Low
$42.06
Volume
13,552
Avg. Vol
7,029
52-wk High
$58.36
52-wk Low
$41.95

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $307.27
Shares Outstanding(Mil.): 7.16
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 196.13 16.04
EPS (TTM): -- -- --
ROI: -- -11.69 35.70
ROE: -- -36.44 15.40

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

Nov 10 2017

BRIEF-BioSpecifics Technologies reports Q2 earnings per share $0.36

* BioSpecifics Technologies Corp reports second quarter 2017 financial results

Aug 09 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $141.65 -1.24
Novartis AG (NOVN.S) CHF83.85 --
Pfizer Inc. (PFE.N) $36.46 -0.18
Roche Holding Ltd. (ROG.S) CHF241.70 0.00
Roche Holding Ltd. (RO.S) CHF242.50 -0.70
Merck & Co., Inc. (MRK.N) $56.01 -0.90
Bayer AG (BAYGn.DE) €105.75 +0.65
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.77 -0.89
GlaxoSmithKline plc (GSK.L) 1,290.50 --

Earnings vs. Estimates